Please use this identifier to cite or link to this item:
Title: EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.
Authors: Babu Rajendran, Nithya
Gladstone, Beryl Primrose
Rodríguez-Baño, Jesús
Sifakis, Frangiscos
Voss, Andreas
Carmeli, Yehuda
Burkert, Francesco Robert
Gkolia, Panagiota
Tacconelli, Evelina
Keywords: EPIDEMIOLOGY;antimicrobial resistance;outbreak
metadata.dc.subject.mesh: Acinetobacter baumannii
Bacterial Infections
Bacterial Proteins
Disease Outbreaks
Drug Resistance, Bacterial
Escherichia coli
Klebsiella pneumoniae
Methicillin-Resistant Staphylococcus aureus
Pseudomonas aeruginosa
Research Design
Systematic Reviews as Topic
Vancomycin-Resistant Enterococci
beta-Lactam Resistance
Issue Date: 5-Jan-2017
Abstract: Improving our understanding of outbreaks due to antibiotic-resistant bacteria (ARB) and their control is critical in the current public health scenario. The threat of outbreaks due to ARB requires multifaceted efforts. However, a global overview of epidemiological characteristics of outbreaks due to ARB and effective infection control measures is missing. In this paper, we describe the protocol of a systematic review aimed at mapping and characterising the epidemiological aspects of outbreaks due to ARB and infection control measures in European countries. The databases MEDLINE, Web of Knowledge and Cochrane library will be searched using a 3-step search strategy. Selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. All study designs will be included if they report an outbreak and define the microbiological methods used for microorganism identification. The target bacteria will be methicillin-resistant and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, ceftazidime-resistant and carbapenem-resistant Acinetobacter baumannii, ceftazidime-resistant and carbapenem-resistant Pseudomonas aeruginosa, ciprofloxacin-resistant Escherichia coli, extended-spectrum β-lactamase-producing E. coli and Klebsiella pneumoniae, carbapenem-resistant and carbapenamase-producing Enterobacteriaceae. Data will be extracted using a tailored pilot tested form and the quality of reporting will be assessed using the ORION (Outbreak Reports and Intervention Studies Of Nosocomial infections) tool. Data will be synthesised and reported by the type of ARB, setting and country. Infection control measures and bundles of measures will be described. The effectiveness will be reported as defined by the authors. Regression analysis will be used to define independent factors associated with outbreaks' control. Heterogeneity between studies will be assessed by forest plots and I² statistics. Ethical approval is not applicable for this study. Findings will be disseminated through journal publication and conference presentations and talks.
metadata.dc.identifier.doi: 10.1136/bmjopen-2016-013634
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5223682.pdf467,64 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons